BioWorld-International-2003-04-30
Diatos Licenses European Rights To Cancer Drug From Medarex
Diatos Licenses European Rights To Cancer Drug From Medarex
PARIS - Diatos SA and Medarex Inc. signed a licensing agreement giving Diatos exclusive European rights to develop and commercialize a potential new cancer treatment. (BioWorld International)

